Coppell Advisory Solutions’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.96M Buy
+58
New +$21.5K 0.82% 26
2025
Q1
Sell
-204
Closed -$75.3K 769
2024
Q4
$75.3K Sell
204
-4
-2% -$1.67K 0.01% 485
2024
Q3
$109K Buy
208
+55
+36% +$29.4K 0.02% 383
2024
Q2
$82.9K Buy
+153
New +$80.9K 0.01% 398
2023
Q4
$115K Buy
244
+221
+961% +$102K 0.02% 342
2023
Q3
$11.8K Sell
23
-3
-12% -$1.36K ﹤0.01% 584
2023
Q2
$11.4K Buy
+26
New +$12K ﹤0.01% 663
2023
Q1
Sell
-23
Closed -$11.8K 454
2022
Q4
$11.8K Buy
+23
New +$11.7K ﹤0.01% 586

Other funds holding ELV

Coppell Advisory Solutions's ELV Position: Q2 2026 in Review

Coppell Advisory Solutions opened a new position in Elevance Health (ELV) in Q2 2026: 58 shares worth $9.96M. The stake represents 0.82% of the portfolio and ranks #26 among its holdings. This is a return to the name: Coppell Advisory Solutions previously reported a position in ELV as recently as Q4 2024.

Coppell Advisory Solutions first reported a position in ELV in Q4 2022 and has held it in 8 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Coppell Advisory Solutions held 58 shares of Elevance Health worth $9.96M as of Q2 2026.
  • Elevance Health was a new Coppell Advisory Solutions position in Q2 2026.
  • Elevance Health made up 0.82% of Coppell Advisory Solutions's portfolio in Q2 2026, its #26 holding.
  • Coppell Advisory Solutions first reported a position in Elevance Health in Q4 2022 and has held it in 8 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Coppell Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.